Sancuso
(granisetron)168 HR granisetron 0.129 MG/HR Transdermal System [Sancuso]
NO BLACK BOX WARNING
Dosage & administration
The recommended dosage is a single transdermal system applied to the upper outer arm a minimum of 24 hours, up to a maximum of 48 hours, before chemotherapy. The transdermal system should be worn at minimum, 24 hours after chemotherapy is finished. The transdermal system can be worn for up to 7 days.
biomarker testing
Sancuso clinical details
Genetic testing requirements were obtained from the NCCN guidelines for each cancer type. drug label
Sancuso prescribing information
samples
Request Sancuso samples
Learn MoreIs my patient elegible for Sancuso samples?
- Your rep will communicate with you how to receive samples, when you can receive samples, the amount and more.
How do I find out who my Sancuso rep is?
- Not sure who your local Sancuso pharma rep is? Reach out to Kyowa Kirin, Inc. and they can help you identify your rep.
prior authorization
Sancuso prior authorization resources
pharmacy
Sancuso preferred pharmacy
financial assistance
Sancuso financial assistance options
Co-pay savings program
Learn MoreOverview
- Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)
Patient benefit
- A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max
Patient eligibility
- Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
- Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
- May never be used with government insurance
How to sign up
- Cards may be downloadable digital cards or hard copies
- Some pharmacos offer debit cards with pre-loaded copay benefit
- Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
- Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form
Foundation programs
Learn MoreOverview
- Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
- These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned
Patient benefit
- Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted
Patient eligibility
- Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.
How to sign up
- Patients submit proof of out-of-pocket drug costs to charities for reimbursement
patient education
Sancuso patient education
Getting started on Sancuso
To share resource; ask patient to: 1.Pull out phone
2.Open camera
3.Scan QR code with camera
Other resources
Learn MoreOther resources brands publish to help support patients.
people also ask
Sancuso FAQs
How is the dosage of Sancuso?Sancuso is available in 1 dosages, including 0.129 mg/hr 168 HR Patch
What does Sancuso treat?Sancuso treats
What is Sancuso made of?Sancuso contains granisetron which is a Serotonin-3 Receptor Antagonist
How Is Sancuso Administered?Sancuso is administered as a Transdermal
What Are The Sancuso Mechanism Of Action?Sancuso mechanism of action is Serotonin 3 Receptor Antagonists
We receive information directly from the FDA and PrescriberPoint is updated as frequently as change are made available
